Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory B-cell Lymphoma

Explore clinical trials studying Relapsed/Refractory B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

10 public trials 3 recruiting studies

Relapsed/Refractory B-cell Lymphoma trial results

Conditions
Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Shanghai Jiao Tong University School of Medicine-Ruijin Hospital Shanghai, Shanghai Municipality, China
  • Tianjin Medical University Cancer Institute&Hospital Tianjin, Tianjin Municipality, China
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Advent Health Orlando, Florida, United States
  • Karmanos Cancer Center Detroit, Michigan, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States